| Sandra Hartman, | |
|
11690 Neelsville Church Rd, Germantown, MD 20876-4127 | |
| (301) 353-0972 | |
| Not Available |
| Full Name | Sandra Hartman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 11690 Neelsville Church Rd, Germantown, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093283343 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 01482 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sandra Hartman, 22213 Canterfield Way, Germantown, MD 20876-4373 Ph: (240) 476-1929 | Sandra Hartman, 11690 Neelsville Church Rd, Germantown, MD 20876-4127 Ph: (301) 353-0972 |
News Archive
In two separate studies, a major component in green tea, epigallocatechin-3-O-gallate (EGCG), has been found to help prolong the preservation of both stored blood platelets and cryopreserved skin tissues.
Cleveland Clinic researchers have discovered a new subtype of multiple sclerosis, providing a better understanding of the individualized nature of the disease.
Lilly UK announced today that Alimta( (pemetrexed) will be available shortly for the treatment of people diagnosed with mesothelioma, a cancer of the lining of the lungs for which there is no known cure. Pemetrexed is the first licenced treatment for malignant pleural mesothelioma, in combination with cisplatin.
Aeterna Zentaris Inc. today announced that Johanna Bendell, MD, Director of Gastrointestinal Cancer Research and Associate Director of Drug Development at the Sarah Cannon Research Institute in Nashville, Tennessee, presented Phase 3 results for perifosine in refractory colorectal cancer yesterday, at the American Society of Clinical Oncology (ASCO) Annual Meeting which is being held in Chicago.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
› Verified 6 days ago
Samantha Blair Becker, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13100 Waters Landing Dr, Germantown, MD 20874 Phone: 240-740-1020 | |
Lauren Grace Dovin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18501 Cinnamon Dr. Germantown, Germantown, MD 20874 Phone: 240-740-2180 | |
Debbie Lerner, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13010 Dairymaid Dr, Germantown, MD 20874 Phone: 301-353-8500 | |
Jill Arends, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20410 Century Blvd, Nrh Regional Rehab - Suite 215, Germantown, MD 20874 Phone: 301-540-6140 Fax: 301-540-5190 | |
Dr. Christina Marie Blomquist, MA, PHD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20400 Observation Dr Ste 104, Germantown, MD 20876 Phone: 240-503-5341 | |
Amaris Anglero, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19733 Executive Park Cir, Germantown, MD 20874 Phone: 301-540-0445 |